These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19702552)

  • 1. Therapeutic potential of 5-HT7 receptors in mood disorders.
    Mnie-Filali O; Lambas-Señas L; Scarna H; Haddjeri N
    Curr Drug Targets; 2009 Nov; 10(11):1109-17. PubMed ID: 19702552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of central 5-HT receptors and their function.
    Barnes NM; Sharp T
    Neuropharmacology; 1999 Aug; 38(8):1083-152. PubMed ID: 10462127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin receptor subtypes and affective disorders.
    Robinson DS
    Clin Neuropharmacol; 1993; 16 Suppl 3():S1-5. PubMed ID: 8131151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-ht5A receptors as a therapeutic target.
    Thomas DR
    Pharmacol Ther; 2006 Sep; 111(3):707-14. PubMed ID: 16516972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional, molecular and pharmacological advances in 5-HT7 receptor research.
    Hedlund PB; Sutcliffe JG
    Trends Pharmacol Sci; 2004 Sep; 25(9):481-6. PubMed ID: 15559250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 5-HT
    Maxwell J; Gleason SD; Falcone J; Svensson K; Balcer OM; Li X; Witkin JM
    Behav Brain Res; 2019 Feb; 359():467-473. PubMed ID: 30471311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible involvement of 5-HT₇ receptor in pathophysiology of affective disorders and action of antidepressant drugs].
    Tokarski K; Kusek M; Sowa J; Bobula B
    Postepy Hig Med Dosw (Online); 2014 Sep; 68():1104-13. PubMed ID: 25228519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease.
    Hirano K; Piers TM; Searle KL; Miller ND; Rutter AR; Chapman PF
    Life Sci; 2009 Apr; 84(15-16):558-62. PubMed ID: 19302808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT7 receptor antagonists as a new class of antidepressants.
    Mnie-Filali O; Lambás-Señas L; Zimmer L; Haddjeri N
    Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-hydroxytryptamine (5-HT) receptor ligands.
    Kitson SL
    Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 5-HT
    Balcer OM; Seager MA; Gleason SD; Li X; Rasmussen K; Maxwell JK; Nomikos G; Degroot A; Witkin JM
    Behav Brain Res; 2019 Mar; 360():270-278. PubMed ID: 30543903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in 5-HT1B/1D receptor antagonists and agonists and their potential therapeutic applications.
    Slassi A
    Curr Top Med Chem; 2002 Jun; 2(6):559-74. PubMed ID: 12052194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease.
    Upton N; Chuang TT; Hunter AJ; Virley DJ
    Neurotherapeutics; 2008 Jul; 5(3):458-69. PubMed ID: 18625457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT(6) receptor and cognition.
    Codony X; Vela JM; Ramírez MJ
    Curr Opin Pharmacol; 2011 Feb; 11(1):94-100. PubMed ID: 21330210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions.
    Barrett JE; Vanover KE
    Psychopharmacology (Berl); 1993; 112(1):1-12. PubMed ID: 7870996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis.
    Kroeze WK; Roth BL
    Biol Psychiatry; 1998 Dec; 44(11):1128-42. PubMed ID: 9836016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.